Galentic Pharma India Pvt. Ltd.

Galentic Pharma India Pvt. Ltd. is a pharmaceutical company engaged in the development and manufacturing of high-quality semi-solid Finished Dosage Forms, particularly sterile ophthalmic and dermatological products designed for specific healthcare needs. Founded in 1992 and headquartered in Mumbai, India, Galentic Pharma India Pvt.

Ltd. specializes in producing pharmaceutical solutions. The company has consistently focused on enhancing its product line to meet diverse healthcare demands, expanding its operations in the process. Galentic Pharma India Pvt.

Ltd. specializes in the development and manufacturing of semi-solid Finished Dosage Forms (FDFs), focusing primarily on sterile ophthalmic products and a diverse range of dermatological topicals. The company’s core product offerings include ophthalmic ointments, gels, and various dermatological formulations, such as creams, lotions, and medicated shampoos. These products are designed to address specific healthcare concerns, including conditions affecting eye health and skin disorders like dermatitis and eczema.

Galentic Pharma aims to enhance patient outcomes by providing effective solutions that adhere to the highest safety and efficacy standards. The company serves a global client base, exporting products to numerous countries while ensuring compliance with international regulatory requirements. Galentic Pharma operates through a structured transaction model that includes partnerships with healthcare providers and distributors in both B2B and direct-to-consumer markets. The company’s revenue is generated through the sale of its specialized pharmaceutical products, which cater to the needs of healthcare professionals and end users.

Transactions typically involve bulk orders of their flagship products, such as their ophthalmic gels and dermatological ointments, facilitated through established distribution channels. This robust distribution network enables Galentic to supply its products efficiently to various geographical markets, optimizing reach and accessibility for healthcare providers and end consumers alike. The pricing strategy reflects the specialized nature of their offerings, designed to ensure affordability while maintaining high-quality standards.